Related Experiment Videos
Do different dialysis-membranes affect beta 2-microglobulin kinetics during chronic hemodialysis?
Abstract:
Hemodialysis is not an absolute prerequisite for the formation of beta 2-microglobulin amyloidosis, but it enhances the progression of this complication related to long-standing renal failure. Thus the clearance and turnover of beta 2-microglobulin seems to play a major role in this disease. In a prospective multicenter study the beta 2-microglobulin clearance was studied in 87 patients starting hemodialysis. Serum samples were taken prior to and after the first dialysis session and also before and after dialysis at 4, 6, 12, 16, 26 and 52 weeks. Patients were either treated by cuprophane or a polyacrylonitril membrane. At the start, the mean serum beta 2-microglobulin level was about 18 mg/L in patients treated with a cuprophane membrane, but the levels increased after hemodialysis and reached a plateau, which was always higher than in those treated with polyacrylonitril, which cleared beta 2-microglobulin from the serum. However, after 12 months the difference was no longer significant. Thus beta 2-microglobulin excretion during dialysis differs between the two membranes, but seems to lose its significance for the beta 2-microglobulin serum level in chronic hemodialysis treatment.
Insights
Beta 2-microglobulin amyloidosis progression is linked to hemodialysis, not solely caused by it. Dialysis membrane type influences beta 2-microglobulin clearance, but this difference diminishes over time in chronic hemodialysis patients.
Area of Science:
- Nephrology
- Biochemistry
- Materials Science
Background:
- Beta 2-microglobulin (B2M) amyloidosis is a complication of long-standing renal failure.
- Hemodialysis can enhance the progression of B2M amyloidosis.
- The clearance and turnover of B2M are critical factors in this disease.
Purpose of the Study:
- To investigate the role of hemodialysis in B2M amyloidosis.
- To compare B2M clearance using different dialysis membranes.
- To analyze B2M serum levels over time in hemodialysis patients.
Main Methods:
- Prospective multicenter study involving 87 patients initiating hemodialysis.
- Serum B2M levels measured before and after dialysis sessions at multiple time points up to 52 weeks.
- Comparison of cuprophane and polyacrylonitrile membranes for B2M clearance.
Main Results:
- Initial B2M levels were higher with cuprophane membranes post-dialysis compared to polyacrylonitrile.
- Polyacrylonitrile membranes showed effective B2M clearance from serum.
- Differences in B2M excretion between membranes became insignificant after 12 months of chronic hemodialysis.
Conclusions:
- Hemodialysis membrane type impacts initial B2M clearance.
- The long-term significance of membrane-specific B2M clearance on serum levels diminishes with chronic hemodialysis.
- B2M turnover plays a major role in the pathogenesis of B2M amyloidosis in renal failure patients.